Selected research
Industry Research
DNA Cloning Service Industry Research Report 2026
Market perspective
The global DNA Cloning Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the DNA Cloning Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the DNA Cloning Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the DNA Cloning Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of DNA Cloning Service include Genscript Biotech, Yunzhou Biosciences, Twist Bioscience Corporation, Azenta, Eurofins Genomics, Thermo Fisher Scientific, Synbio Technologies, Bioneer Corporation and Macrogen, Inc., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global DNA Cloning Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to DNA Cloning Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
DNA Cloning Service Market by Company
Genscript Biotech
Yunzhou Biosciences
Twist Bioscience Corporation
Azenta
Eurofins Genomics
Thermo Fisher Scientific
Synbio Technologies
Bioneer Corporation
Macrogen, Inc.
OriGene Technologies
Creative Biogene
InvivoGen
Bio Basic Inc.
Biomatik
GeneCopoeia, Inc.
NovoPro Bioscience Inc.
System Biosciences
Porton Advanced
uBriGene
Aurigene Services
Beijing Tsingke Biotech
Sangon Biotech
Shandong Vigene Biosciences
Shanghai Medicilon
Shanghai Integrated Biotech Solutions
Wuhan Miaoling Biotechnology
Shanghai ShineGene Molecular Biotechnology
FASMAC
DNA Cloning Service e.K.
PlasmidFactory GmbH
DNA Cloning Service Segment by Type
Common Plasmid
Expression Plasmid
Phage Vector
Other
DNA Cloning Service Segment by Application
Biomedicine
Gene and Cell Therapy
Research Institutions
Synthetic Biology
Other
DNA Cloning Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Cloning Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Cloning Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Cloning Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of DNA Cloning Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Common Plasmid
- Expression Plasmid
- Phage Vector
- Other
Applications
- Biomedicine
- Gene and Cell Therapy
- Research Institutions
- Synthetic Biology
- Other
Companies covered
- Genscript Biotech
- Yunzhou Biosciences
- Twist Bioscience Corporation
- Azenta
- Eurofins Genomics
- Thermo Fisher Scientific
- Synbio Technologies
- Bioneer Corporation
- Macrogen, Inc.
- OriGene Technologies
- Creative Biogene
- InvivoGen
- Bio Basic Inc.
- Biomatik
- GeneCopoeia, Inc.
- NovoPro Bioscience Inc.
- System Biosciences
- Porton Advanced
- uBriGene
- Aurigene Services
- Beijing Tsingke Biotech
- Sangon Biotech
- Shandong Vigene Biosciences
- Shanghai Medicilon
- Shanghai Integrated Biotech Solutions
- Wuhan Miaoling Biotechnology
- Shanghai ShineGene Molecular Biotechnology
- FASMAC
- DNA Cloning Service e.K.
- PlasmidFactory GmbH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 DNA Cloning Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Common Plasmid
- 2.2.3 Expression Plasmid
- 2.2.4 Phage Vector
- 2.2.5 Other
- 2.3 DNA Cloning Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biomedicine
- 2.3.3 Gene and Cell Therapy
- 2.3.4 Research Institutions
- 2.3.5 Synthetic Biology
- 2.3.6 Other
- 2.4 Assumptions and Limitations
3 DNA Cloning Service Breakdown Data by Type
- 3.1 Global DNA Cloning Service Historic Market Size by Type (2021-2026)
- 3.2 Global DNA Cloning Service Forecasted Market Size by Type (2027-2032)
4 DNA Cloning Service Breakdown Data by Application
- 4.1 Global DNA Cloning Service Historic Market Size by Application (2021-2026)
- 4.2 Global DNA Cloning Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global DNA Cloning Service Market Perspective (2021-2032)
- 5.2 Global DNA Cloning Service Growth Trends by Region
- 5.2.1 Global DNA Cloning Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 DNA Cloning Service Historic Market Size by Region (2021-2026)
- 5.2.3 DNA Cloning Service Forecasted Market Size by Region (2027-2032)
- 5.3 DNA Cloning Service Market Dynamics
- 5.3.1 DNA Cloning Service Industry Trends
- 5.3.2 DNA Cloning Service Market Drivers
- 5.3.3 DNA Cloning Service Market Challenges
- 5.3.4 DNA Cloning Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top DNA Cloning Service Players by Revenue
- 6.1.1 Global Top DNA Cloning Service Players by Revenue (2021-2026)
- 6.1.2 Global DNA Cloning Service Revenue Market Share by Players (2021-2026)
- 6.2 Global DNA Cloning Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of DNA Cloning Service Head Office and Area Served
- 6.4 Global DNA Cloning Service Players, Product Type & Application
- 6.5 Global DNA Cloning Service Manufacturers Established Date
- 6.6 Global DNA Cloning Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America DNA Cloning Service Market Size (2021-2032)
- 7.2 North America DNA Cloning Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America DNA Cloning Service Market Size by Country (2021-2026)
- 7.4 North America DNA Cloning Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe DNA Cloning Service Market Size (2021-2032)
- 8.2 Europe DNA Cloning Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe DNA Cloning Service Market Size by Country (2021-2026)
- 8.4 Europe DNA Cloning Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific DNA Cloning Service Market Size (2021-2032)
- 9.2 Asia-Pacific DNA Cloning Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific DNA Cloning Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific DNA Cloning Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America DNA Cloning Service Market Size (2021-2032)
- 10.2 South America DNA Cloning Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America DNA Cloning Service Market Size by Country (2021-2026)
- 10.4 South America DNA Cloning Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa DNA Cloning Service Market Size (2021-2032)
- 11.2 Middle East & Africa DNA Cloning Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa DNA Cloning Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa DNA Cloning Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Genscript Biotech
- 12.1.1 Genscript Biotech Company Information
- 12.1.2 Genscript Biotech Business Overview
- 12.1.3 Genscript Biotech Revenue in DNA Cloning Service Business (2021-2026)
- 12.1.4 Genscript Biotech DNA Cloning Service Product Portfolio
- 12.1.5 Genscript Biotech Recent Developments
- 12.2 Yunzhou Biosciences
- 12.2.1 Yunzhou Biosciences Company Information
- 12.2.2 Yunzhou Biosciences Business Overview
- 12.2.3 Yunzhou Biosciences Revenue in DNA Cloning Service Business (2021-2026)
- 12.2.4 Yunzhou Biosciences DNA Cloning Service Product Portfolio
- 12.2.5 Yunzhou Biosciences Recent Developments
- 12.3 Twist Bioscience Corporation
- 12.3.1 Twist Bioscience Corporation Company Information
- 12.3.2 Twist Bioscience Corporation Business Overview
- 12.3.3 Twist Bioscience Corporation Revenue in DNA Cloning Service Business (2021-2026)
- 12.3.4 Twist Bioscience Corporation DNA Cloning Service Product Portfolio
- 12.3.5 Twist Bioscience Corporation Recent Developments
- 12.4 Azenta
- 12.4.1 Azenta Company Information
- 12.4.2 Azenta Business Overview
- 12.4.3 Azenta Revenue in DNA Cloning Service Business (2021-2026)
- 12.4.4 Azenta DNA Cloning Service Product Portfolio
- 12.4.5 Azenta Recent Developments
- 12.5 Eurofins Genomics
- 12.5.1 Eurofins Genomics Company Information
- 12.5.2 Eurofins Genomics Business Overview
- 12.5.3 Eurofins Genomics Revenue in DNA Cloning Service Business (2021-2026)
- 12.5.4 Eurofins Genomics DNA Cloning Service Product Portfolio
- 12.5.5 Eurofins Genomics Recent Developments
- 12.6 Thermo Fisher Scientific
- 12.6.1 Thermo Fisher Scientific Company Information
- 12.6.2 Thermo Fisher Scientific Business Overview
- 12.6.3 Thermo Fisher Scientific Revenue in DNA Cloning Service Business (2021-2026)
- 12.6.4 Thermo Fisher Scientific DNA Cloning Service Product Portfolio
- 12.6.5 Thermo Fisher Scientific Recent Developments
- 12.7 Synbio Technologies
- 12.7.1 Synbio Technologies Company Information
- 12.7.2 Synbio Technologies Business Overview
- 12.7.3 Synbio Technologies Revenue in DNA Cloning Service Business (2021-2026)
- 12.7.4 Synbio Technologies DNA Cloning Service Product Portfolio
- 12.7.5 Synbio Technologies Recent Developments
- 12.8 Bioneer Corporation
- 12.8.1 Bioneer Corporation Company Information
- 12.8.2 Bioneer Corporation Business Overview
- 12.8.3 Bioneer Corporation Revenue in DNA Cloning Service Business (2021-2026)
- 12.8.4 Bioneer Corporation DNA Cloning Service Product Portfolio
- 12.8.5 Bioneer Corporation Recent Developments
- 12.9 Macrogen, Inc.
- 12.9.1 Macrogen, Inc. Company Information
- 12.9.2 Macrogen, Inc. Business Overview
- 12.9.3 Macrogen, Inc. Revenue in DNA Cloning Service Business (2021-2026)
- 12.9.4 Macrogen, Inc. DNA Cloning Service Product Portfolio
- 12.9.5 Macrogen, Inc. Recent Developments
- 12.10 OriGene Technologies
- 12.10.1 OriGene Technologies Company Information
- 12.10.2 OriGene Technologies Business Overview
- 12.10.3 OriGene Technologies Revenue in DNA Cloning Service Business (2021-2026)
- 12.10.4 OriGene Technologies DNA Cloning Service Product Portfolio
- 12.10.5 OriGene Technologies Recent Developments
- 12.11 Creative Biogene
- 12.11.1 Creative Biogene Company Information
- 12.11.2 Creative Biogene Business Overview
- 12.11.3 Creative Biogene Revenue in DNA Cloning Service Business (2021-2026)
- 12.11.4 Creative Biogene DNA Cloning Service Product Portfolio
- 12.11.5 Creative Biogene Recent Developments
- 12.12 InvivoGen
- 12.12.1 InvivoGen Company Information
- 12.12.2 InvivoGen Business Overview
- 12.12.3 InvivoGen Revenue in DNA Cloning Service Business (2021-2026)
- 12.12.4 InvivoGen DNA Cloning Service Product Portfolio
- 12.12.5 InvivoGen Recent Developments
- 12.13 Bio Basic Inc.
- 12.13.1 Bio Basic Inc. Company Information
- 12.13.2 Bio Basic Inc. Business Overview
- 12.13.3 Bio Basic Inc. Revenue in DNA Cloning Service Business (2021-2026)
- 12.13.4 Bio Basic Inc. DNA Cloning Service Product Portfolio
- 12.13.5 Bio Basic Inc. Recent Developments
- 12.14 Biomatik
- 12.14.1 Biomatik Company Information
- 12.14.2 Biomatik Business Overview
- 12.14.3 Biomatik Revenue in DNA Cloning Service Business (2021-2026)
- 12.14.4 Biomatik DNA Cloning Service Product Portfolio
- 12.14.5 Biomatik Recent Developments
- 12.15 GeneCopoeia, Inc.
- 12.15.1 GeneCopoeia, Inc. Company Information
- 12.15.2 GeneCopoeia, Inc. Business Overview
- 12.15.3 GeneCopoeia, Inc. Revenue in DNA Cloning Service Business (2021-2026)
- 12.15.4 GeneCopoeia, Inc. DNA Cloning Service Product Portfolio
- 12.15.5 GeneCopoeia, Inc. Recent Developments
- 12.16 NovoPro Bioscience Inc.
- 12.16.1 NovoPro Bioscience Inc. Company Information
- 12.16.2 NovoPro Bioscience Inc. Business Overview
- 12.16.3 NovoPro Bioscience Inc. Revenue in DNA Cloning Service Business (2021-2026)
- 12.16.4 NovoPro Bioscience Inc. DNA Cloning Service Product Portfolio
- 12.16.5 NovoPro Bioscience Inc. Recent Developments
- 12.17 System Biosciences
- 12.17.1 System Biosciences Company Information
- 12.17.2 System Biosciences Business Overview
- 12.17.3 System Biosciences Revenue in DNA Cloning Service Business (2021-2026)
- 12.17.4 System Biosciences DNA Cloning Service Product Portfolio
- 12.17.5 System Biosciences Recent Developments
- 12.18 Porton Advanced
- 12.18.1 Porton Advanced Company Information
- 12.18.2 Porton Advanced Business Overview
- 12.18.3 Porton Advanced Revenue in DNA Cloning Service Business (2021-2026)
- 12.18.4 Porton Advanced DNA Cloning Service Product Portfolio
- 12.18.5 Porton Advanced Recent Developments
- 12.19 uBriGene
- 12.19.1 uBriGene Company Information
- 12.19.2 uBriGene Business Overview
- 12.19.3 uBriGene Revenue in DNA Cloning Service Business (2021-2026)
- 12.19.4 uBriGene DNA Cloning Service Product Portfolio
- 12.19.5 uBriGene Recent Developments
- 12.20 Aurigene Services
- 12.20.1 Aurigene Services Company Information
- 12.20.2 Aurigene Services Business Overview
- 12.20.3 Aurigene Services Revenue in DNA Cloning Service Business (2021-2026)
- 12.20.4 Aurigene Services DNA Cloning Service Product Portfolio
- 12.20.5 Aurigene Services Recent Developments
- 12.21 Beijing Tsingke Biotech
- 12.21.1 Beijing Tsingke Biotech Company Information
- 12.21.2 Beijing Tsingke Biotech Business Overview
- 12.21.3 Beijing Tsingke Biotech Revenue in DNA Cloning Service Business (2021-2026)
- 12.21.4 Beijing Tsingke Biotech DNA Cloning Service Product Portfolio
- 12.21.5 Beijing Tsingke Biotech Recent Developments
- 12.22 Sangon Biotech
- 12.22.1 Sangon Biotech Company Information
- 12.22.2 Sangon Biotech Business Overview
- 12.22.3 Sangon Biotech Revenue in DNA Cloning Service Business (2021-2026)
- 12.22.4 Sangon Biotech DNA Cloning Service Product Portfolio
- 12.22.5 Sangon Biotech Recent Developments
- 12.23 Shandong Vigene Biosciences
- 12.23.1 Shandong Vigene Biosciences Company Information
- 12.23.2 Shandong Vigene Biosciences Business Overview
- 12.23.3 Shandong Vigene Biosciences Revenue in DNA Cloning Service Business (2021-2026)
- 12.23.4 Shandong Vigene Biosciences DNA Cloning Service Product Portfolio
- 12.23.5 Shandong Vigene Biosciences Recent Developments
- 12.24 Shanghai Medicilon
- 12.24.1 Shanghai Medicilon Company Information
- 12.24.2 Shanghai Medicilon Business Overview
- 12.24.3 Shanghai Medicilon Revenue in DNA Cloning Service Business (2021-2026)
- 12.24.4 Shanghai Medicilon DNA Cloning Service Product Portfolio
- 12.24.5 Shanghai Medicilon Recent Developments
- 12.25 Shanghai Integrated Biotech Solutions
- 12.25.1 Shanghai Integrated Biotech Solutions Company Information
- 12.25.2 Shanghai Integrated Biotech Solutions Business Overview
- 12.25.3 Shanghai Integrated Biotech Solutions Revenue in DNA Cloning Service Business (2021-2026)
- 12.25.4 Shanghai Integrated Biotech Solutions DNA Cloning Service Product Portfolio
- 12.25.5 Shanghai Integrated Biotech Solutions Recent Developments
- 12.26 Wuhan Miaoling Biotechnology
- 12.26.1 Wuhan Miaoling Biotechnology Company Information
- 12.26.2 Wuhan Miaoling Biotechnology Business Overview
- 12.26.3 Wuhan Miaoling Biotechnology Revenue in DNA Cloning Service Business (2021-2026)
- 12.26.4 Wuhan Miaoling Biotechnology DNA Cloning Service Product Portfolio
- 12.26.5 Wuhan Miaoling Biotechnology Recent Developments
- 12.27 Shanghai ShineGene Molecular Biotechnology
- 12.27.1 Shanghai ShineGene Molecular Biotechnology Company Information
- 12.27.2 Shanghai ShineGene Molecular Biotechnology Business Overview
- 12.27.3 Shanghai ShineGene Molecular Biotechnology Revenue in DNA Cloning Service Business (2021-2026)
- 12.27.4 Shanghai ShineGene Molecular Biotechnology DNA Cloning Service Product Portfolio
- 12.27.5 Shanghai ShineGene Molecular Biotechnology Recent Developments
- 12.28 FASMAC
- 12.28.1 FASMAC Company Information
- 12.28.2 FASMAC Business Overview
- 12.28.3 FASMAC Revenue in DNA Cloning Service Business (2021-2026)
- 12.28.4 FASMAC DNA Cloning Service Product Portfolio
- 12.28.5 FASMAC Recent Developments
- 12.29 DNA Cloning Service e.K.
- 12.29.1 DNA Cloning Service e.K. Company Information
- 12.29.2 DNA Cloning Service e.K. Business Overview
- 12.29.3 DNA Cloning Service e.K. Revenue in DNA Cloning Service Business (2021-2026)
- 12.29.4 DNA Cloning Service e.K. DNA Cloning Service Product Portfolio
- 12.29.5 DNA Cloning Service e.K. Recent Developments
- 12.30 PlasmidFactory GmbH
- 12.30.1 PlasmidFactory GmbH Company Information
- 12.30.2 PlasmidFactory GmbH Business Overview
- 12.30.3 PlasmidFactory GmbH Revenue in DNA Cloning Service Business (2021-2026)
- 12.30.4 PlasmidFactory GmbH DNA Cloning Service Product Portfolio
- 12.30.5 PlasmidFactory GmbH Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst